EMFAT
KITE

Emerald Mutual Fund Advisers Trust’s Kite Pharma, Inc. KITE Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-17,750
Closed -$513K – 241
2014
Q2 		$513K Buy
+17,750
New +$529K 0.05% 191

Other funds holding KITE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SFM
Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's KITE Position: Q3 2014 in Review

Emerald Mutual Fund Advisers Trust sold out of Kite Pharma, Inc. (KITE) in Q3 2014, closing a stake of 17,750 shares — an estimated $513K sold.

Emerald Mutual Fund Advisers Trust first reported a position in KITE in Q2 2014 and held it in 1 quarter. The position peaked at $513K in Q2 2014. 62 funds tracked by Wall St. Rank hold KITE as of Q3 2014.

  • Emerald Mutual Fund Advisers Trust reported no remaining Kite Pharma, Inc. position as of Q3 2014 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 17,750 Kite Pharma, Inc. shares in Q3 2014, an estimated $513K.
  • Emerald Mutual Fund Advisers Trust first reported a position in Kite Pharma, Inc. in Q2 2014 and held it in 1 quarter.
  • Emerald Mutual Fund Advisers Trust's Kite Pharma, Inc. position peaked at $513K in Q2 2014.
  • 62 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q3 2014.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q3 2014, filed 28 Oct 2014.